Topic: regulatory affairs

Camargo_HighGrowth_listing_250x190

Maximizing the Value of Your Drug Development Program

This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2) drug development and how to save time and money while maximizing the value of their drug development program.
Scott Gottlieb FDA

FDA hit by government shutdown

A political deadlock that led to a partial government shutdown before Christmas could take some of the shine off a golden year of FDA approvals.